CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Australia

Date: 2016-10

“CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Australia


GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Australia”. The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Australia. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

The population of Australia in 2015 was 23.86 million, having grown at a CAGR of 2% from 2008. Medicare is Australia’s public health insurance scheme, and provides free or subsidized healthcare services to the Australian population. The government is attempting to reduce the barriers to manufacturing drugs and encourage exports through the introduction of various new policies.

In 2015, the government spent $22.03 billion on R&D on medical and health science and exported $3.53 billion of pharmaceutical products. The pharmaceutical market in Australia was worth $22.30 billion in 2015 and is projected to reach $25.20 billion by 2020, at a Compound Annual Growth Rate (CAGR) of 2%. The medical device market was valued at $8.85 billion in 2015 and is projected to grow at a CAGR of 0.1% to $11.44 billion by 2020. These positive growth trends can be primarily attributed to –
– An increasingly elderly population
– Universal health coverage
– Government initiatives


The report provides information on the healthcare, regulatory, and reimbursement landscape in Australia, and includes –
– An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
– Profiles and SWOT analyses of the major players in the pharmaceutical market: Alphapharm, Apotex, Aspen Pharmacare (Aspen), Pfizer and AstraZeneca; and profiles and SWOT analyses of the major players in the medical device market: GE Healthcare, Siemens Healthcare, Philips Healthcare, GSK and Alcon
– An insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
– Detailed analysis of the country’s political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
– An overview of the opportunities for and challenges to growth in the Australian healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to –
– Develop business strategies by understanding the trends shaping and driving Australia’s healthcare market
– Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Australia’s healthcare market in the future
– Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
– Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership”

Contact With Us
Join templatemonster at google+
Customized Research
Request Sample